The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
500 jobs Number of planned job creations
Announcement Date
5 March 2009
Employment effect (start)
Foreseen end date
Description
Octopharma, one of the world's largest privately owned processors of plasma and makers of blood products, is to establish a plasma processing laboratory in Poland which will employ 500 persons. The general outline of this project was presented to the Polish government in the spring 2008; as of March 2009, there i no information on the location of the laboratory, the timeframe for its completion and the employment start date.
Sources
5 March 2009: Polska Agencja Prasowa Webside (www.pap.pl)
Citation
Eurofound (2009), Octopharma, Business expansion in Poland, factsheet number 68469, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/68469.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
